List of insiders holdings for enGene Holdings Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Forbion Growth Sponsor FEAC I B.V. Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner | 2024-11-01 16:04:56 | 9,201,434 0 | 9,201,434 | Form 13D |
| 2 | Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner | 2024-11-01 16:15:08 | 3,032,430 3,765,932 | 6,798,362 | Form 4 |
| 3 | Forbion Capital Fund III Cooperatief U.A. Forbion III Management B.V. 10% Owner | 2024-02-14 07:21:55 | 3,369,275 0 | 3,369,275 | Form 13G |
| 4 | Lumira Capital Investment Management Inc. 10% Owner | 2024-02-21 16:20:10 | 0 2,855,648 | 2,855,648 | Form 4 |
| 5 | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC 10% Owner | 2024-10-21 12:35:47 | 2,029,751 0 | 2,029,751 | Form 13G |
| 6 | Hanson Jason David Chief Executive Officer | 2023-11-02 16:09:58 | 1,216,266 0 | 1,216,266 | Form 4 |
| 7 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 2025-01-29 17:12:06 | 945,402 0 | 945,402 | Form 13G |
| 8 | Cooper Ronald Harold Wilfred CEO & President | 2025-01-31 16:36:39 | 850,000 0 | 850,000 | Form 4 |
| 9 | Pruthi Raj Som Chief Medical Officer | 2025-01-31 16:46:11 | 280,000 0 | 280,000 | Form 4 |
| 10 | Daws D. Ryan Chief Financial Officer | 2025-01-31 16:40:20 | 280,000 0 | 280,000 | Form 4 |
| 11 | Nichols Alexander Julian Chief Strategy & Ops. Ofc | 2025-01-31 16:44:27 | 250,000 0 | 250,000 | Form 4 |
| 12 | Giguere Lee Chief Legal Ofc. and Corp Secy | 2025-01-31 16:42:31 | 250,000 0 | 250,000 | Form 4 |
| 13 | CHEUNG ANTHONY TZEYEW Chief Scientific Officer | 2025-01-31 16:38:24 | 250,000 0 | 250,000 | Form 4 |
| 14 | Connolly Joan Chief Technology Officer | 2024-10-22 16:07:13 | 210,000 0 | 210,000 | Form 4 |
| 15 | Sullivan James Crowley Chief Scientific Officer | 2023-11-02 16:09:31 | 207,410 0 | 207,410 | Form 4 |
| 16 | BRYCE RICHARD PAUL Chief Medical Officer | 2023-12-04 17:55:37 | 153,000 0 | 153,000 | Form 4 |
| 17 | Joustra Wouter Director | 2024-06-18 16:08:01 | 40,000 0 | 40,000 | Form 4 |
| 18 | HASTINGS PAUL J Director | 2024-06-18 16:08:51 | 40,000 0 | 40,000 | Form 4 |
| 19 | Zoth Lota S. Director | 2024-06-18 16:09:40 | 20,000 0 | 20,000 | Form 4 |
| 20 | Glickman Richard M Director | 2024-06-18 16:06:48 | 20,000 0 | 20,000 | Form 4 |
| 21 | Bos Jasper Director | 2024-06-18 16:05:02 | 20,000 0 | 20,000 | Form 4 |
| 22 | BRUNK GERALD A Director | 2024-06-18 16:04:17 | 20,000 0 | 20,000 | Form 4 |
| 23 | Grassin Alexandre Jean-Rene Erwan Int. Chief Financial Officer | 2023-10-31 18:02:41 | 0 0 | 0 | Form 3 |
| 24 | Pott Amy Chief Global Comm. Ofc. | 2025-05-29 17:30:57 | 0 0 | 0 | Form 3 |